Research output per year
Research output per year
Fingerprint
Dive into the research topics where Julia Maxson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Research output
-
Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report
Carratt, S. A., Brewer, D., Maxson, J. E., Druker, B. J. & Braun, T. P., Dec 2021, In: Biomarker Research. 9, 1, 8.Research output: Contribution to journal › Article › peer-review
Open Access -
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia
Braun, T. P., Coblentz, C., Smith, B. M., Coleman, D. J., Schonrock, Z., Carratt, S. A., Callahan, R. L., Maniaci, B., Druker, B. J. & Maxson, J., Jun 16 2020, In: Proceedings of the National Academy of Sciences of the United States of America. 117, 24, p. 13670-13679 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia
Dao, K. H. T., Gotlib, J., Deininger, M. M. N., Oh, S. T., Cortes, J. E., Collins, R. H., Winton, E. F., Parker, D. R., Lee, H., Schultz, A. R., Stevens, S. S., Brockett, C., Subbiah, N., Press, R. D., Raess, P. W., Cascio, M., Dunlap, J., Chen, Y., Degnin, C., Maxson, J. E. & 4 others, , Apr 1 2020, In: Journal of Clinical Oncology. 38, 10, p. 1006-1018 13 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy
Stoner, R. C., Press, R. D., Maxson, J. E., Tyner, J. W. & Dao, K. H. T., Jun 1 2020, In: Leukemia. 34, 6, p. 1684-1688 5 p.Research output: Contribution to journal › Article › peer-review
-
Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia
Tarlock, K., Alonzo, T., Wang, Y. C., Gerbing, R. B., Ries, R. E., Hylkema, T., Smith, J. L., Maxson, J. E. & Meshinchi, S., Apr 30 2020, In: Blood. 135, 18, p. 1603-1606 4 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations